The Singapore Cancer Registry has provided comprehensive population-based i
ncidence data since 1968, This paper describes the population-based surviva
l analysis of the registry data. All invasive primary cancers diagnosed fro
m January 1, 1968 to December 31, 1992 were passively followed up until Dec
ember 31, 1997. Only 5.8% were lost to follow-up. Cumulative and observed s
urvival rates were calculated using Hakulinen's method. Overall 5-year rela
tive survival rates have increased dramatically over the 25-year period in
both genders. Significant increases are seen with nasopharynx, stomach and
colo-rectum cancers, non-Hodgkin's lymphoma, leukemias and cancers of the t
estis, cervix, ovaries and breast. When compared with the Surveillance, Epi
demiology and End Results (SEER) rates in the United States, the 5-year rel
ative survival rates in Singapore are generally lower, However, the rate of
change between the two countries is fairly similar. On the average, the ra
tes are IO to 15 years behind the SEER rates and 5 to 10 years behind Finla
nd, Switzerland and Japan, but they are close to the UK rates. The age-stan
dardized 5-year survival rate for Singapore is higher for most sites compar
ed with other developing countries like Qidong (China), Madras (India), Bom
bay (India) and Chiang Mai (Thailand), The 25-year trend in cancer survival
in Singapore showed two extreme groups: those showing no change and those
showing significant improvements. Reducing the incidence of cancers belongi
ng to the first group remains the only viable mode of cancer control. For c
ancers in the second group, improvement in survival is due to a combination
of successful early detection measures and effective treatment services in
Singapore. (C) 2001 Wiley-Liss, Inc.